Diversified Trust Co raised its position in shares of Novanta Inc. (NASDAQ:NOVT - Free Report) by 47.0% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,293 shares of the technology company's stock after purchasing an additional 2,011 shares during the period. Diversified Trust Co's holdings in Novanta were worth $805,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in NOVT. Proficio Capital Partners LLC bought a new stake in Novanta in the 4th quarter worth $5,298,000. Versor Investments LP bought a new stake in shares of Novanta in the 4th quarter worth approximately $275,000. Mutual of America Capital Management LLC increased its stake in shares of Novanta by 6.7% during the fourth quarter. Mutual of America Capital Management LLC now owns 46,153 shares of the technology company's stock valued at $7,051,000 after buying an additional 2,912 shares during the period. SBI Securities Co. Ltd. purchased a new position in shares of Novanta during the fourth quarter valued at approximately $97,000. Finally, Arizona State Retirement System raised its holdings in shares of Novanta by 0.7% during the fourth quarter. Arizona State Retirement System now owns 10,412 shares of the technology company's stock valued at $1,591,000 after acquiring an additional 76 shares in the last quarter. Institutional investors own 98.35% of the company's stock.
Wall Street Analyst Weigh In
Several analysts have commented on the stock. Wall Street Zen upgraded shares of Novanta from a "hold" rating to a "buy" rating in a report on Friday, June 6th. Robert W. Baird decreased their target price on Novanta from $169.00 to $160.00 and set a "neutral" rating for the company in a research report on Monday, March 3rd.
Check Out Our Latest Research Report on NOVT
Novanta Stock Performance
Shares of NASDAQ NOVT traded up $1.89 during midday trading on Tuesday, hitting $130.82. 242,046 shares of the stock traded hands, compared to its average volume of 221,090. The firm has a market capitalization of $4.71 billion, a P/E ratio of 66.75 and a beta of 1.45. Novanta Inc. has a one year low of $98.76 and a one year high of $187.12. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.70 and a current ratio of 2.56. The firm has a 50-day moving average of $124.27 and a two-hundred day moving average of $134.43.
Novanta (NASDAQ:NOVT - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The technology company reported $0.74 earnings per share for the quarter, topping the consensus estimate of $0.68 by $0.06. Novanta had a net margin of 7.42% and a return on equity of 15.06%. The business had revenue of $233.37 million for the quarter, compared to the consensus estimate of $233.34 million. During the same period last year, the firm earned $0.74 earnings per share. The company's quarterly revenue was up 1.1% on a year-over-year basis. On average, equities analysts forecast that Novanta Inc. will post 3.03 EPS for the current fiscal year.
Novanta Profile
(
Free Report)
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Further Reading

Before you consider Novanta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novanta wasn't on the list.
While Novanta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.